| Datum | Zeit | Quelle | Überschrift | Symbol | Firma |
| 09/10/2008 | 19h03 | Edgar (US Regulatory) | Statement of Beneficial Ownership (SC 13D) | AMEX:PP | Meet Kevin Pricing Power ETF |
| 06/10/2008 | 14h30 | Marketwired | Pipex Pharmaceuticals to Present at the Maxim Group Growth Conference on October 7th | AMEX:PP | Meet Kevin Pricing Power ETF |
| 19/09/2008 | 14h30 | Marketwired | Pipex Pharmaceuticals' Oral TRIMESTA Phase IIa Clinical and Preclinical Findings Presented at World Congress on Treatment and Re | AMEX:PP | Meet Kevin Pricing Power ETF |
| 29/08/2008 | 23h01 | Edgar (US Regulatory) | Pipex Pharmaceuticals, Inc. - Amended Annual Report (Small Business Issuers) (10KSB/A) | AMEX:PP | Meet Kevin Pricing Power ETF |
| 19/08/2008 | 14h54 | Marketwired | Pipex Pharmaceuticals Acquires Late-Stage Oral Phase II Candidate for Rheumatoid Arthritis | AMEX:PP | Meet Kevin Pricing Power ETF |
| 19/08/2008 | 14h30 | Marketwired | Pipex Pharmaceuticals, Inc. to Present at the RedChip Small Cap Investor Conference in New York City | AMEX:PP | Meet Kevin Pricing Power ETF |
| 14/08/2008 | 22h49 | Edgar (US Regulatory) | Pipex Pharmaceuticals, Inc. - Quarterly Report (10-Q) | AMEX:PP | Meet Kevin Pricing Power ETF |
| 14/08/2008 | 22h18 | Edgar (US Regulatory) | Pipex Pharmaceuticals, Inc. - Current report filing (8-K) | AMEX:PP | Meet Kevin Pricing Power ETF |
| 14/08/2008 | 19h39 | Marketwired | Pipex Pharmaceuticals Announces Clinical Update and Second Quarter 2008 Results | AMEX:PP | Meet Kevin Pricing Power ETF |
| 12/08/2008 | 14h27 | Marketwired | Pipex Pharmaceuticals to Present at the Noble Financial Equity Conference | AMEX:PP | Meet Kevin Pricing Power ETF |
| 15/07/2008 | 14h40 | Edgar (US Regulatory) | Pipex Pharmaceuticals, Inc. - Amended Statement of Beneficial Ownership (SC 13D/A) | AMEX:PP | Meet Kevin Pricing Power ETF |
| 15/07/2008 | 00h45 | Edgar (US Regulatory) | Pipex Pharmaceuticals, Inc. - Statement of Changes in Beneficial Ownership (4) | AMEX:PP | Meet Kevin Pricing Power ETF |
| 09/07/2008 | 20h48 | Edgar (US Regulatory) | Pipex Pharmaceuticals, Inc. - Current report filing (8-K) | AMEX:PP | Meet Kevin Pricing Power ETF |
| 09/07/2008 | 14h38 | Marketwired | Pipex Pharmaceuticals Announces Results of Eighty Patient, Six Month, Prospective, Randomized, Double-Blind Clinical Trial of Or | AMEX:PP | Meet Kevin Pricing Power ETF |
| 08/07/2008 | 23h16 | Edgar (US Regulatory) | Pipex Pharmaceuticals, Inc. - Current report filing (8-K) | AMEX:PP | Meet Kevin Pricing Power ETF |
| 08/07/2008 | 21h54 | Marketwired | Pipex Pharmaceuticals to Host Conference Call at 10:15am ET Wednesday July 9th to Discuss Phase II Clinical Trial Results in Dry | AMEX:PP | Meet Kevin Pricing Power ETF |
| 08/07/2008 | 13h41 | Marketwired | Pipex Pharmaceuticals Appoints Co-Founder and Vice Chairman Nicholas Stergis as Chief Executive Officer | AMEX:PP | Meet Kevin Pricing Power ETF |
| 20/05/2008 | 15h00 | Marketwired | Pipex Pharmaceuticals Announces Issuance of Additional US Patent Covering CD4 Inhibitor Molecules | AMEX:PP | Meet Kevin Pricing Power ETF |
| 16/05/2008 | 16h59 | Edgar (US Regulatory) | Pipex Pharmaceuticals, Inc. - Current report filing (8-K) | AMEX:PP | Meet Kevin Pricing Power ETF |
| 15/05/2008 | 23h13 | Edgar (US Regulatory) | Pipex Pharmaceuticals, Inc. - Quarterly Report (10-Q) | AMEX:PP | Meet Kevin Pricing Power ETF |
| 15/05/2008 | 22h36 | Marketwired | Pipex Pharmaceuticals Announces Clinical Update and First Quarter 2008 Results | AMEX:PP | Meet Kevin Pricing Power ETF |
| 13/05/2008 | 15h05 | Marketwired | Pipex Pharmaceuticals to Provide Clinical Update and Report First Quarter 2008 Results on Thursday, May 15 | AMEX:PP | Meet Kevin Pricing Power ETF |
| 12/05/2008 | 15h23 | Marketwired | Pipex Pharmaceuticals Receives FDA Orphan Drug Designation for Oral TTM for Idiopathic Pulmonary Fibrosis (IPF) | AMEX:PP | Meet Kevin Pricing Power ETF |
| 07/05/2008 | 15h00 | Marketwired | Pipex Pharmaceuticals Announces Notice of Allowance of U.S. Patent for Oral TTM for Alzheimer's Disease | AMEX:PP | Meet Kevin Pricing Power ETF |
| 02/05/2008 | 14h38 | Edgar (US Regulatory) | Pipex Pharmaceuticals, Inc. - Current report filing (8-K) | AMEX:PP | Meet Kevin Pricing Power ETF |
| 29/04/2008 | 21h35 | Edgar (US Regulatory) | Pipex Pharmaceuticals, Inc. - Proxy Statement (definitive) (DEF 14A) | AMEX:PP | Meet Kevin Pricing Power ETF |
| 21/04/2008 | 14h02 | Marketwired | Pipex Pharmaceuticals' Oral Flupirtine Receives IND With FDA for Phase II Clinical Trial for Fibromyalgia | AMEX:PP | Meet Kevin Pricing Power ETF |
| 18/04/2008 | 23h13 | Edgar (US Regulatory) | Pipex Pharmaceuticals, Inc. - Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A) | AMEX:PP | Meet Kevin Pricing Power ETF |
| 15/04/2008 | 17h12 | Edgar (US Regulatory) | Pipex Pharmaceuticals, Inc. - Statement of Changes in Beneficial Ownership (4) | AMEX:PP | Meet Kevin Pricing Power ETF |
| 01/04/2008 | 19h49 | Edgar (US Regulatory) | Pipex Pharmaceuticals, Inc. - Current report filing (8-K) | AMEX:PP | Meet Kevin Pricing Power ETF |